AMPK: Lessons from transgenic and knockout animals

Frontiers in Bioscience

Volumn 14, Issue 1, 2009, Pages 19-44

  Viollet, Benoit ^a,b   Athea, Yoni ^c,d   Mounier, Remi ^a,b   Guigas, Bruno ^e,f   Zarrinpashneh, Elham ^e   Horman, Sandrine ^e   Lantier, Louise ^a,b   Hebrard, Sophie ^a,b   Devin Leclerc, Jocelyne ^a,b   Beauloye, Christophe ^e   Foretz, Marc ^a,b   Andreelli, Fabrizio ^a,b   Ventura Clapier, Renée ^c,d   Bertrand, Luc ^e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c Universite Paris Sud   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AMPK; Animal models; Energy metabolism; Review

Indexed keywords

ANIMALIA;

ANTIDIABETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ADIPOSE TISSUE; ANIMAL; ANIMAL MODEL; BLOOD VESSEL; CHEMISTRY; ENERGY METABOLISM; ENZYMOLOGY; GENE INACTIVATION; HEART MUSCLE; HUMAN; HYPOTHALAMUS; INSULIN RESISTANCE; LIVER; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION; REVIEW; SKELETAL MUSCLE; TRANSGENIC ANIMAL;

ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD VESSELS; ENERGY METABOLISM; GENE KNOCKOUT TECHNIQUES; HUMANS; HYPOGLYCEMIC AGENTS; HYPOTHALAMUS; INSULIN RESISTANCE; LIVER; MODELS, ANIMAL; MUSCLE, SKELETAL; MYOCARDIUM; PROTEIN CONFORMATION;

EID: 63849301000     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3229     Document Type: Article

References (154)

1. B. B. Kahn, T. Alquier, D. Carling and D. G. Hardie: AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1, 15-25(2005) (Pubitemid 43960587)
2. M. J. Sanders, P. O. Grondin, B. D. Hegarty, M. A. Snowden and D. Carling: Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 403, 139-48(2007) (Pubitemid 46569875)
3. M. Suter, U. Riek, R. Tuerk, U. Schlattner, T. Wallimann and D. Neumann: Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J Biol Chem 281, 32207-16(2006) (Pubitemid 46036775)
4. J. F. Wojtaszewski, J. B. Birk, C. Frosig, M. Holten, H. Pilegaard and F. Dela: 5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol 564, 563-73(2005) (Pubitemid 40585054)
5. J. B. Birk and J. F. Wojtaszewski: Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle. J Physiol 577, 1021-32(2006) (Pubitemid 44873663)
6. J. T. Treebak, J. B. Birk, A. J. Rose, B. Kiens, E. A. Richter and J. F. Wojtaszewski: AS160 phosphorylation is associated with activation of alpha2beta2gamma1-but not alpha2beta2gamma3-AMPK trimeric complex in skeletal muscle during exercise in humans. Am J Physiol Endocrinol Metab 292, E715-22 (2007)
7. K. Sakamoto, A. McCarthy, D. Smith, K. A. Green, D. Grahame Hardie, A. Ashworth and D. R. Alessi: Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 24, 1810-20(2005) (Pubitemid 40769500)
8. K. Sakamoto, E. Zarrinpashneh, G. R. Budas, A. C. Pouleur, A. Dutta, A. R. Prescott, J. L. Vanoverschelde, A. Ashworth, A. Jovanovic, D. R. Alessi and L. Bertrand: Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. Am J Physiol Endocrinol Metab 290, E780-8 (2006)
9. B. Viollet, M. Foretz, B. Guigas, S. Horman, R. Dentin, L. Bertrand, L. Hue and F. Andreelli: Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 574, 41-53(2006) (Pubitemid 43905795)
10. S. Jager, C. Handschin, J. St-Pierre and B. M. Spiegelman: AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1{alpha}. Proc Natl Acad Sci USA 104:12017-22(2007) (Pubitemid 47185622)
11. K. R. Hallows, G. P. Kobinger, J. M. Wilson, L. A. Witters and J. K. Foskett: Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am J Physiol Cell Physiol 284, C1297-308 (2003) (Pubitemid 36457411)
12. A. M. Evans, K. J. Mustard, C. N. Wyatt, C. Peers, M. Dipp, P. Kumar, N. P. Kinnear and D. G. Hardie: Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells? J Biol Chem 280, 41504-11(2005) (Pubitemid 41832211)
13. P. C. Cheung, I. P. Salt, S. P. Davies, D. G. Hardie and D. Carling: Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 346, 659-69(2000) (Pubitemid 30171026)
14. S. M. Warden, C. Richardson, J. O'Donnell, Jr., D. Stapleton, B. E. Kemp and L. A. Witters: Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem J 354, 275-83(2001) (Pubitemid 32209863)
15. M. Gregor, A. Zeold, S. Oehler, K. A. Marobela, P. Fuchs, G. Weigel, D. G. Hardie and G. Wiche: Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres. J Cell Sci 119, 1864-75(2006) (Pubitemid 43811012)
16. D. G. Hardie: AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 47, 185-210(2007)
17. S. B. Jorgensen, B. Viollet, F. Andreelli, C. Frosig, J. B. Birk, P. Schjerling, S. Vaulont, E. A. Richter and J. F. Wojtaszewski: Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279, 1070-9(2004) (Pubitemid 38082628)
18. B. Viollet, F. Andreelli, S. B. Jorgensen, C. Perrin, A. Geloen, D. Flamez, J. Mu, C. Lenzner, O. Baud, M. Bennoun, E. Gomas, G. Nicolas, J. F. Wojtaszewski, A. Kahn, D. Carling, F. C. Schuit, M. J. Birnbaum, E. A. Richter, R. Burcelin and S. Vaulont: The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111, 91-8(2003) (Pubitemid 36134852)
19. J. Mu, J. T. Brozinick, Jr., O. Valladares, M. Bucan and M. J. Birnbaum: A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7, 1085-94(2001) (Pubitemid 32525754)
20. D. M. Muoio, K. Seefeld, L. A. Witters and R. A. Coleman: AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338, 783-91(1999) (Pubitemid 29140087)
21. M. Foretz, N. Ancellin, F. Andreelli, Y. Saintillan, P. Grondin, A. Kahn, B. Thorens, S. Vaulont and B. Viollet: Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54, 1331-9(2005) (Pubitemid 40586661)
22. J. A. Baur, K. J. Pearson, N. L. Price, H. A. Jamieson, C. Lerin, A. Kalra, V. V. Prabhu, J. S. Allard, G. Lopez-Lluch, K. Lewis, P. J. Pistell, S. Poosala, K. G. Becker, O. Boss, D. Gwinn, M. Wang, S. Ramaswamy, K. W. Fishbein, R. G. Spencer, E. G. Lakatta, D. Le Couteur, R. J. Shaw, P. Navas, P. Puigserver, D. K. Ingram, R. de Cabo and D. A. Sinclair: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-42(2006) (Pubitemid 44764104)
23. B. Guigas, N. Taleux, M. Foretz, D. Detaille, F. Andreelli, B. Viollet and L. Hue: AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem J 404, 499-507(2007) (Pubitemid 46953924)
24. B. Guigas, L. Bertrand, N. Taleux, M. Foretz, N. Wiernsperger, D. Vertommen, F. Andreelli, B. Viollet and L. Hue: 5-Aminoimidazole-4-Carboxamide- 1-{beta}-D-Ribofuranoside and Metformin Inhibit Hepatic Glucose Phosphorylation by an AMP-Activated Protein Kinase-Independent Effect on Glucokinase Translocation. Diabetes 55, 865-74(2006) (Pubitemid 44100158)
25. R. Bergeron, S. F. Previs, G. W. Cline, P. Perret, R. R. Russell, 3rd, L. H. Young and G. I. Shulman: Effect of 5-aminoimidazole-4-carboxamide-1-beta-D- ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 50, 1076-82(2001) (Pubitemid 32374538)
26. F. Andreelli, M. Foretz, C. Knauf, P. D. Cani, C. Perrin, M. A. Iglesias, B. Pillot, A. Bado, F. Tronche, G. Mithieux, S. Vaulont, R. Burcelin and B. Viollet: Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology 147, 2432-41(2006)
27. R. J. Shaw, K. A. Lamia, D. Vasquez, S. H. Koo, N. Bardeesy, R. A. Depinho, M. Montminy and L. C. Cantley: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-6(2005) (Pubitemid 41780780)
28. H. Satoh, M. T. Nguyen, P. D. Miles, T. Imamura, I. Usui and J. M. Olefsky: Adenovirus-mediated chronic "hyperresistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 114, 224-31(2004) (Pubitemid 39071627)
29. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B. B. Kahn and T. Kadowaki: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288-95(2002) (Pubitemid 35373562)
30. R. Dentin, F. Benhamed, J. P. Pegorier, F. Foufelle, B. Viollet, S. Vaulont, J. Girard and C. Postic: Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J Clin Invest 115, 2843-54(2005) (Pubitemid 41434411)
31. F. Rencurel, M. Foretz, M. R. Kaufmann, D. Stroka, R. Looser, I. Leclerc, G. da Silva Xavier, G. A. Rutter, B. Viollet and U. A. Meyer: Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Mol Pharmacol 70, 1925-34(2006) (Pubitemid 44771908)
32. J. E. Sullivan, K. J. Brocklehurst, A. E. Marley, F. Carey, D. Carling and R. K. Beri: Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cellpermeable activator of AMP-activated protein kinase. FEBS Lett 353, 33-6(1994) (Pubitemid 24312538)
33. S. A. Habinowski and L. A. Witters: The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 286, 852-6(2001) (Pubitemid 32924850)
34. O. Matejkova, K. J. Mustard, J. Sponarova, P. Flachs, M. Rossmeisl, I. Miksik, M. Thomason-Hughes, D. Grahame Hardie and J. Kopecky: Possible involvement of AMP-activated protein kinase in obesity resistance induced by respiratory uncoupling in white fat. FEBS Lett 569, 245-8(2004) (Pubitemid 38844626)
35. M. Rossmeisl, G. Barbatelli, P. Flachs, P. Brauner, M. C. Zingaretti, M. Marelli, P. Janovska, M. Horakova, I. Syrovy, S. Cinti and J. Kopecky: Expression of the uncoupling protein 1 from the aP2 gene promoter stimulates mitochondrial biogenesis in unilocular adipocytes in vivo. Eur J Biochem 269, 19-28(2002) (Pubitemid 34107335)
36. J. M. Corton, J. G. Gillespie, S. A. Hawley and D. G. Hardie: 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229, 558-65(1995)
37. M. Daval, F. Diot-Dupuy, R. Bazin, I. Hainault, B. Viollet, S. Vaulont, E. Hajduch, P. Ferre and F. Foufelle: Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes. J Biol Che, 280, 25250-7(2005) (Pubitemid 40934619)
38. J. A. Villena, B. Viollet, F. Andreelli, A. Kahn, S. Vaulont and H. S. Sul: Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit. Diabetes 53, 2242-9(2004) (Pubitemid 39145577)
39. N. Fujii, T. Hayashi, M. F. Hirshman, J. T. Smith, S. A. Habinowski, L. Kaijser, J. Mu, O. Ljungqvist, M. J. Birnbaum, L. A. Witters, A. Thorell and L. J. Goodyear: Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273, 1150-5(2000) (Pubitemid 30481094)
40. W. W. Winder and D. G. Hardie: Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol Endocrinol Metab 270, E299-304 (1996)
41. D. Vavvas, A. Apazidis, A. K. Saha, J. Gamble, A. Patel, B. E. Kemp, L. A. Witters and N. B. Ruderman: Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem 272, 13255-61(1997) (Pubitemid 27216754)
42. D. G. Hardie and K. Sakamoto: AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology 21, 48-60(2006) (Pubitemid 43752517)
43. N. Fujii, M. M. Seifert, E. M. Kane, L. E. Peter, R. C. Ho, S. Winstead, M. F. Hirshman and L. J. Goodyear: Role of AMP-activated protein kinase in exercise capacity, whole body glucose homeostasis, and glucose transport in skeletal muscle-Insight from analysis of a transgenic mouse model. Diabetes Res Clin Pract 77, S92-8 (2007) (Pubitemid 47225133)
44. S. B. Jorgensen, J. T. Treebak, B. Viollet, P. Schjerling, S. Vaulont, J. F. Wojtaszewski and E. A. Richter: Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Am J Physiol Endocrinol Metab 292, E331-9 (2007) (Pubitemid 46052958)
45. S. B. Jorgensen, J. F. Wojtaszewski, B. Viollet, F. Andreelli, J. B. Birk, Y. Hellsten, P. Schjerling, S. Vaulont, P. D. Neufer, E. A. Richter and H. Pilegaard: Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. FASEB J 19, 1146-8(2005) (Pubitemid 40946446)
46. B. F. Holmes, D. B. Lang, M. J. Birnbaum, J. Mu and G. L. Dohm: AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle. Am J Physiol Endocrinol Metab 287, E739-43 (2004) (Pubitemid 39237903)
47. K. S. Rockl, M. F. Hirshman, J. Brandauer, N. Fujii, L. A. Witters and L. J. Goodyear: Skeletal Muscle Adaptation to Exercise Training: AMP-Activated Protein Kinase Mediates Muscle Fiber Type Shift. Diabetes 56, 2062-9(2007) (Pubitemid 47195818)
48. W. W. Winder, B. F. Holmes, D. S. Rubink, E. B. Jensen, M. Chen and J. O. Holloszy: Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88, 2219-26(2000) (Pubitemid 30453931)
49. R. Bergeron, J. M. Ren, K. S. Cadman, I. K. Moore, P. Perret, M. Pypaert, L. H. Young, C. F. Semenkovich and G. I. Shulman: Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281, E1340-6 (2001)
50. S. Terada, M. Goto, M. Kato, K. Kawanaka, T. Shimokawa and I. Tabata: Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun 296, 350-4(2002)
51. K. S. Rockl, M. F. Hirshman, J. Brandauer, N. Fujii, L. A. Witters and L. J. Goodyear: Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 56, 2062-9(2007) (Pubitemid 47195818)
52. H. Zong, J. M. Ren, L. H. Young, M. Pypaert, J. Mu, M. J. Birnbaum and G. I. Shulman: AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA 99, 15983-7(2002) (Pubitemid 35462735)
53. R. M. Reznick, H. Zong, J. Li, K. Morino, I. K. Moore, H. J. Yu, Z. X. Liu, J. Dong, K. J. Mustard, S. A. Hawley, D. Befroy, M. Pypaert, D. G. Hardie, L. H. Young and G. I. Shulman: Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab 5, 151-6(2007) (Pubitemid 46172924)
54. D. R. Bolster, S. J. Crozier, S. R. Kimball and L. S. Jefferson: AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 277, 23977-80(2002) (Pubitemid 34951907)
55. D. M. Thomson and S. E. Gordon: Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation. J Appl Physiol 98, 557-64(2005) (Pubitemid 40129965)
56. D. M. Thomson and S. E. Gordon: Impaired overloadinduced muscle growth is associated with diminished translational signalling in aged rat fast-twitch skeletal muscle. J Physiol 574, 291-305(2006) (Pubitemid 43905813)
57. N. Kimura, C. Tokunaga, S. Dalal, C. Richardson, K. Yoshino, K. Hara, B. E. Kemp, L. A. Witters, O. Mimura and K. Yonezawa: A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8, 65-79(2003) (Pubitemid 36511694)
58. A. Y. Chan, C. L. Soltys, M. E. Young, C. G. Proud and J. R. Dyck: Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J Biol Chem 279, 32771-9(2004) (Pubitemid 39014736)
59. S. Horman, G. Browne, U. Krause, J. Patel, D. Vertommen, L. Bertrand, A. Lavoinne, L. Hue, C. Proud and M. Rider: Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol 12, 1419-23(2002) (Pubitemid 34915545)
60. U. Krause, L. Bertrand and L. Hue: Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur J Biochem 269, 3751-9(2002) (Pubitemid 34989124)
61. K. Inoki, T. Zhu and K. L. Guan: TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-90(2003) (Pubitemid 37506046)
62. S. W. Cheng, L. G. Fryer, D. Carling and P. R. Shepherd: Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J Biol Chem 279, 15719-22(2004) (Pubitemid 38509255)
63. V. Aguilar, S. Alliouachene, A. Sotiropoulos, A. Sobering, Y. Athea, F. Djouadi, S. Miraux, E. Thiaudiere, M. Foretz, B. Viollet, P. Diolez, J. Bastin, P. Benit, P. Rustin, D. Carling, M. Sandri, R. Ventura-Clapier and M. Pende: S6 Kinase Deletion Suppresses Muscle Growth Adaptations to Nutrient Availability by Activating AMP Kinase. Cell Metab 5, 476-87(2007) (Pubitemid 46825498)
64. N. Fujii, M. F. Hirshman, E. M. Kane, R. C. Ho, L. E. Peter, M. M. Seifert and L. J. Goodyear: AMP-activated protein kinase alpha2 activity is not essential for contraction-and hyperosmolarity-induced glucose transport in skeletal muscle. J Biol Chem 280, 39033-41(2005) (Pubitemid 41713853)
65. B. R. Barnes, S. Marklund, T. L. Steiler, M. Walter, G. Hjalm, V. Amarger, M. Mahlapuu, Y. Leng, C. Johansson, D. Galuska, K. Lindgren, M. Abrink, D. Stapleton, J. R. Zierath and L. Andersson: The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279, 38441-7(2004) (Pubitemid 39295995)
66. J. Mu, E. R. Barton and M. J. Birnbaum: Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'. Biochem Soc Trans 31, 236-41(2003) (Pubitemid 36241436)
67. H. F. Kramer, C. A. Witczak, N. Fujii, N. Jessen, E. B. Taylor, D. E. Arnolds, K. Sakamoto, M. F. Hirshman and L. J. Goodyear: Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55, 2067-76(2006) (Pubitemid 44509981)
68. J. T. Treebak, S. Glund, A. Deshmukh, D. K. Klein, Y. C. Long, T. E. Jensen, S. B. Jorgensen, B. Viollet, L. Andersson, D. Neumann, T. Wallimann, E. A. Richter, A. V. Chibalin, J. R. Zierath and J. F. Wojtaszewski: AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55, 2051-8(2006) (Pubitemid 44509979)
69. G. F. Merrill, E. J. Kurth, D. G. Hardie and W. W. Winder: AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273, E1107-12 (1997)
70. Y. Minokoshi, Y. B. Kim, O. D. Peroni, L. G. Fryer, C. Muller, D. Carling and B. B. Kahn: Leptin stimulates fattyacid oxidation by activating AMP-activated protein kinase. Nature 415, 339-43(2002) (Pubitemid 34087557)
71. B. R. Barnes, S. Glund, Y. C. Long, G. Hjalm, L. Andersson and J. R. Zierath: 5'-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics. FASEB J 19, 773-9(2005) (Pubitemid 40617381)
72. M. A. Raney and L. P. Turcotte: Regulation of contraction-induced FA uptake and oxidation by AMPK and ERK1/2 is intensity dependent in rodent muscle. Am J Physiol Endocrinol Metab 291, E1220-7 (2006) (Pubitemid 44904029)
73. M. A. Raney, A. J. Yee, M. K. Todd and L. P. Turcotte: AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction. Am J Physiol Endocrinol Metab 288, E592-8 (2005) (Pubitemid 40250555)
74. A. C. Smith, C. R. Bruce and D. J. Dyck: AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle. J Physiol 565, 547-53(2005) (Pubitemid 40872481)
75. S. B. Jorgensen, J. N. Nielsen, J. B. Birk, G. S. Olsen, B. Viollet, F. Andreelli, P. Schjerling, S. Vaulont, D. G. Hardie, B. F. Hansen, E. A. Richter and J. F. Wojtaszewski: The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. Diabetes 53, 3074-81(2004) (Pubitemid 39564481)
76. H. Yu, M. F. Hirshman, N. Fujii, J. M. Pomerleau, L. E. Peter and L. J. Goodyear: Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation. Am J Physiol Endocrinol Metab 291, E557-65 (2006) (Pubitemid 44352262)
77. L. Barre, C. Richardson, M. F. Hirshman, J. Brozinick, S. Fiering, B. E. Kemp, L. J. Goodyear and L. A. Witters: Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation. Am J Physiol Endocrinol Metab 292, E802-11 (2007) (Pubitemid 46411058)
78. J. R. Dyck and G. D. Lopaschuk: AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 574, 95-112(2006) (Pubitemid 43905800)
79. L. Hue, C. Beauloye, L. Bertrand, S. Horman, U. Krause, A. S. Marsin, D. Meisse, D. Vertommen and M. H. Rider: New targets of AMP-activated protein kinase. Biochem Soc Trans 31, 213-5(2003) (Pubitemid 36241430)
80. L. Hue, C. Beauloye, A. S. Marsin, L. Bertrand, S. Horman and M. H. Rider: Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. J Mol Cell Cardiol 34, 1091-7(2002) (Pubitemid 35205153)
81. L. H. Young, J. Li, S. J. Baron and R. R. Russell: AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 15, 110-8(2005) (Pubitemid 41021735)
82. E. Zarrinpashneh, K. Carjaval, C. Beauloye, A. Ginion, P. Mateo, A. C. Pouleur, S. Horman, S. Vaulont, J. Hoerter, B. Viollet, L. Hue, J. L. Vanoverschelde and L. Bertrand: Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. Am J Physiol Heart Circ Physiol 291, H2875-83 (2006) (Pubitemid 44904088)
83. R. R. Russell, 3rd, J. Li, D. L. Coven, M. Pypaert, C. Zechner, M. Palmeri, F. J. Giordano, J. Mu, M. J. Birnbaum and L. H. Young: AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114, 495-503(2004) (Pubitemid 39572099)
84. K. Carvajal, E. Zarrinpashneh, O. Szarszoi, F. Joubert, Y. Athea, P. Mateo, B. Gillet, S. Vaulont, B. Viollet, X. Bigard, L. Bertrand, R. Ventura-Clapier and J. A. Hoerter: Dual cardiac contractile effects of the {alpha}2-AMPK deletion in low-flow ischemia and reperfusion. Am J Physiol Heart Circ Physiol 292, H3136-47 (2007) (Pubitemid 47084569)
85. Y. Xing, N. Musi, N. Fujii, L. Zou, I. Luptak, M. F. Hirshman, L. J. Goodyear and R. Tian: Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J Biol Chem 278, 28372-7(2003) (Pubitemid 36935737)
86. M. Arad, C. E. Seidman and J. G. Seidman: AMP-activated protein kinase in the heart: role during health and disease. Circ Res 100, 474-88(2007) (Pubitemid 46673257)
87. J. S. Sidhu, Y. S. Rajawat, T. G. Rami, M. H. Gollob, Z. Wang, R. Yuan, A. J. Marian, F. J. DeMayo, D. Weilbacher, G. E. Taffet, J. K. Davies, D. Carling, D. S. Khoury and R. Roberts: Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation 111, 21-9(2005) (Pubitemid 40070839)
88. M. Arad, I. P. Moskowitz, V. V. Patel, F. Ahmad, A. R. Perez-Atayde, D. B. Sawyer, M. Walter, G. H. Li, P. G. Burgon, C. T. Maguire, D. Stapleton, J. P. Schmitt, X. X. Guo, A. Pizard, S. Kupershmidt, D. M. Roden, C. I. Berul, C. E. Seidman and J. G. Seidman: Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 107, 2850-6(2003) (Pubitemid 36705997)
89. I. Luptak, M. Shen, H. He, M. F. Hirshman, N. Musi, L. J. Goodyear, J. Yan, H. Wakimoto, H. Morita, M. Arad, C. E. Seidman, J. G. Seidman, J. S. Ingwall, J. A. Balschi and R. Tian: Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. J Clin Invest 117, 1432-9(2007) (Pubitemid 46718431)
90. J. K. Davies, D. J. Wells, K. Liu, H. R. Whitrow, T. D. Daniel, R. Grignani, C. A. Lygate, J. E. Schneider, G. Noel, H. Watkins and D. Carling: Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. Am J Physiol Heart Circ Physiol 290, H1942-51 (2006)
91. S. K. Banerjee, R. Ramani, S. Saba, J. Rager, R. Tian, M. A. Mathier and F. Ahmad: A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia. Biochem Biophys Res Commun 360, 381-7(2007) (Pubitemid 47033891)
92. M. Xie, D. Zhang, J. R. Dyck, Y. Li, H. Zhang, M. Morishima, D. L. Mann, G. E. Taffet, A. Baldini, D. S. Khoury and M. D. Schneider: A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci USA 103, 17378-83(2006) (Pubitemid 44788977)
93. J. Li, E. J. Miller, J. Ninomiya-Tsuji, R. R. Russell, 3rd and L. H. Young: AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ Res 97, 872-9(2005) (Pubitemid 41552672)
94. A. Sukhodub, S. Jovanovic, Q. Du, G. Budas, A. K. Clelland, M. Shen, K. Sakamoto, R. Tian and A. Jovanovic: AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K (+) channels. J Cell Physiol 210, 224-36(2007) (Pubitemid 44904718)
95. Y. Athea, B. Viollet, P. Mateo, D. Rousseau, M. Novotova, A. Garnier, S. Vaulont, J. R. Wilding, A. Grynberg, V. Veksler, J. Hoerter and R. Ventura-Clapier: AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function. Diabetes 56, 786-94(2007) (Pubitemid 46348483)
96. B. J. Davis, Z. Xie, B. Viollet and M. H. Zou: Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 55, 496-505(2006) (Pubitemid 43343281)
97. M. H. Zou, S. S. Kirkpatrick, B. J. Davis, J. S. Nelson, W. G. t. Wiles, U. Schlattner, D. Neumann, M. Brownlee, M. B. Freeman and M. H. Goldman: Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J Biol Chem 279, 43940-51(2004) (Pubitemid 39390702)
98. L. J. Rubin, L. Magliola, X. Feng, A. W. Jones and C. C. Hale: Metabolic activation of AMP kinase in vascular smooth muscle. J Appl Physiol 98, 296-306(2005) (Pubitemid 40041260)
99. E. S. Buhl, N. Jessen, R. Pold, T. Ledet, A. Flyvbjerg, S. B. Pedersen, O. Pedersen, O. Schmitz and S. Lund: Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51, 2199-206(2002) (Pubitemid 34729025)
100. Z. P. Chen, K. I. Mitchelhill, B. J. Michell, D. Stapleton, I. Rodriguez-Crespo, L. A. Witters, D. A. Power, P. R. Ortiz de Montellano and B. E. Kemp: AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443, 285-9(1999) (Pubitemid 29080812)
101. V. A. Morrow, F. Foufelle, J. M. Connell, J. R. Petrie, G. W. Gould and I. P. Salt: Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem 278, 31629-39(2003) (Pubitemid 37048341)
102. F. Goirand, M. Solar, Y. Athea, B. Viollet, P. Mateo, D. Fortin, J. Leclerc, J. Hoerter, R. Ventura-Clapier and A. Garnier: Activation of AMP kinase {alpha}1 subunit induces aortic vasorelaxation in mice. J Physiol 581, 1163-71(2007) (Pubitemid 46887985)
103. G. J. Morton, D. E. Cummings, D. G. Baskin, G. S. Barsh and M. W. Schwartz: Central nervous system control of food intake and body weight. Nature 443, 289-95(2006) (Pubitemid 44435142)
104. M. S. Kim and K. U. Lee: Role of hypothalamic 5'-AMP-activated protein kinase in the regulation of food intake and energy homeostasis. J Mol Med 83, 514-20(2005)
105. S. Ramamurthy and G. V. Ronnett: Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J Physiol 574, 85-93(2006) (Pubitemid 43905799)
106. B. Xue and B. B. Kahn: AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol 574, 73-83(2006) (Pubitemid 43905798)
107. Y. Minokoshi, T. Alquier, N. Furukawa, Y. B. Kim, A. Lee, B. Xue, J. Mu, F. Foufelle, P. Ferre, M. J. Birnbaum, B. J. Stuck and B. B. Kahn: AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-74(2004) (Pubitemid 38480541)
108. U. Andersson, K. Filipsson, C. R. Abbott, A. Woods, K. Smith, S. R. Bloom, D. Carling and C. J. Small: AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279, 12005-8(2004) (Pubitemid 38445761)
109. M. S. Kim, J. Y. Park, C. Namkoong, P. G. Jang, J. W. Ryu, H. S. Song, J. Y. Yun, I. S. Namgoong, J. Ha, I. S. Park, I. K. Lee, B. Viollet, J. H. Youn, H. K. Lee and K. U. Lee: Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 10, 727-33(2004) (Pubitemid 38937638)
110. K. Lee, B. Li, X. Xi, Y. Suh and R. J. Martin: Role of neuronal energy status in the regulation of adenosine 5'-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. Endocrinology 146, 3-10(2005) (Pubitemid 40051714)
111. E. K. Kim, I. Miller, S. Aja, L. E. Landree, M. Pinn, J. McFadden, F. P. Kuhajda, T. H. Moran and G. V. Ronnett: C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J Biol Chem 279, 19970-6(2004) (Pubitemid 38623439)
112. B. Kola, E. Hubina, S. A. Tucci, T. C. Kirkham, E. A. Garcia, S. E. Mitchell, L. M. Williams, S. A. Hawley, D. G. Hardie, A. B. Grossman and M. Korbonits: Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem 280, 25196-201(2005) (Pubitemid 40934612)
113. N. Kubota, W. Yano, T. Kubota, T. Yamauchi, S. Itoh, H. Kumagai, H. Kozono, I. Takamoto, S. Okamoto, T. Shiuchi, R. Suzuki, H. Satoh, A. Tsuchida, M. Moroi, K. Sugi, T. Noda, H. Ebinuma, Y. Ueta, T. Kondo, E. Araki, O. Ezaki, R. Nagai, K. Tobe, Y. Terauchi, K. Ueki, Y. Minokoshi and T. Kadowaki: Adiponectin Stimulates AMP-Activated Protein Kinase in the Hypothalamus and Increases Food Intake. Cell Metab 6, 55-68(2007) (Pubitemid 47007437)
114. S. Tovar, R. Nogueiras, L. Y. Tung, T. R. Castaneda, M. J. Vazquez, A. Morris, L. M. Williams, S. L. Dickson and C. Dieguez: Central administration of resistin promotes short-term satiety in rats. Eur J Endocrinol 153, R1-5 (2005) (Pubitemid 41410504)
115. E. D. Muse, T. K. Lam, P. E. Scherer and L. Rossetti: Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest 117, 1670-8(2007) (Pubitemid 46871351)
116. R. Palanivel and G. Sweeney: Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett 579, 5049-54(2005) (Pubitemid 41242851)
117. D. Cota, K. Proulx, K. A. Smith, S. C. Kozma, G. Thomas, S. C. Woods and R. J. Seeley: Hypothalamic mTOR signaling regulates food intake. Science 312, 927-30(2006) (Pubitemid 43727328)
118. T. K. Lam, G. J. Schwartz and L. Rossetti: Hypothalamic sensing of fatty acids. Nature neuroscience 8, 579-84(2005) (Pubitemid 40594197)
119. M. J. Wolfgang and M. D. Lane: The role of hypothalamic malonyl-CoA in energy homeostasis. J Biol Chem 281, 37265-9(2006) (Pubitemid 46042029)
120. N. Sambandam, M. Steinmetz, A. Chu, J. Y. Altarejos, J. R. Dyck and G. D. Lopaschuk: Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5'AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique. Eur J Biochem 271, 2831-40(2004) (Pubitemid 38869984)
121. S. Obici, Z. Feng, A. Arduini, R. Conti and L. Rossetti: Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9, 756-61(2003) (Pubitemid 36749226)
122. W. He, T. K. Lam, S. Obici and L. Rossetti: Molecular disruption of hypothalamic nutrient sensing induces obesity. Nature Neurosci 9, 227-33(2006) (Pubitemid 43164546)
123. M. J. Wolfgang, T. Kurama, Y. Dai, A. Suwa, M. Asaumi, S. Matsumoto, S. H. Cha, T. Shimokawa and M. D. Lane: The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc Natl Acad Sci USA 103, 7282-7(2006) (Pubitemid 43727824)
124. M. Claret, M. A. Smith, R. L. Batterham, C. Selman, A. I. Choudhury, L. G. Fryer, M. Clements, H. Al-Qassab, H. Heffron, A. W. Xu, J. R. Speakman, G. S. Barsh, B. Viollet, S. Vaulont, M. L. Ashford, D. Carling and D. J. Withers: AMPK is essential for energy homeostasis regulation and glucose-sensing by POMC and AgRP neurons J Clin Invest, 117, 2325-36(2007) (Pubitemid 47219577)
125. J. A. Tschape, C. Hammerschmied, M. Muhlig-Versen, K. Athenstaedt, G. Daum and D. Kretzschmar: The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing. EMBO J 21, 6367-76(2002) (Pubitemid 35448415)
126. L. D. McCullough, Z. Zeng, H. Li, L. E. Landree, J. McFadden and G. V. Ronnett: Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 280, 20493-502(2005) (Pubitemid 40776749)
127. J. H. Lee, H. Koh, M. Kim, Y. Kim, S. Y. Lee, R. E. Karess, S. H. Lee, M. Shong, J. M. Kim, J. Kim and J. Chung: Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447, 1017-20(2007) (Pubitemid 46975745)
128. V. Mirouse, L. L. Swick, N. Kazgan, D. St Johnston and J. E. Brenman: LKB1 and AMPK maintain epithelial cell polarity under energetic stress. J Cell Biol 177, 387-92(2007) (Pubitemid 46718268)
129. R. J. Shaw, N. Bardeesy, B. D. Manning, L. Lopez, M. Kosmatka, R. A. DePinho and L. C. Cantley: The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6, 91-9(2004) (Pubitemid 38903165)
130. R. G. Jones, D. R. Plas, S. Kubek, M. Buzzai, J. Mu, Y. Xu, M. J. Birnbaum and C. B. Thompson: AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18, 283-93(2005) (Pubitemid 41350534)
131. J. Apfeld, G. O'Connor, T. McDonagh, P. S. DiStefano and R. Curtis: The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 18, 3004-9(2004) (Pubitemid 39658169)
132. P. Narbonne and R. Roy: Inhibition of germline proliferation during C. elegans dauer development requires PTEN, LKB1 and AMPK signalling. Development 133, 611-9(2006)
133. R. Curtis, G. O'Connor and P. S. DiStefano: Aging networks in Caenorhabditis elegans: AMP-activated protein kinase (aak-2) links multiple aging and metabolism pathways. Aging Cell 5, 119-26(2006) (Pubitemid 44056503)
134. E. L. Greer, D. Dowlatshahi, M. R. Banko, J. Villen, K. Hoang, D. Blanchard, S. P. Gygi and A. Brunet: An AMPK-FOXO Pathway Mediates Longevity Induced by a Novel Method of Dietary Restriction in C. elegans. Curr Biol 17, 1646-56(2007) (Pubitemid 47503807)
135. E. L. Greer, P. R. Oskoui, M. R. Banko, J. M. Maniar, M. P. Gygi, S. P. Gygi and A. Brunet: The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor. J Biol Chem 282, 30107-19(2007) (Pubitemid 350035296)
136. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M. F. Hirshman, L. J. Goodyear and D. E. Moller: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167-74(2001) (Pubitemid 32995375)
137. L. Bertrand, A. Ginion, C. Beauloye, A. D. Hebert, B. Guigas, L. Hue and J. L. Vanoverschelde: AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Physiol Heart Circ Physiol 291, H239-50 (2006)
138. L. Zhang, H. He and J. A. Balschi: Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. Am J Physiol Heart Circ Physiol 293, H457-66 (2007) (Pubitemid 47105103)
139. B. Cool, B. Zinker, W. Chiou, L. Kifle, N. Cao, M. Perham, R. Dickinson, A. Adler, G. Gagne, R. Iyengar, G. Zhao, K. Marsh, P. Kym, P. Jung, H. S. Camp and E. Frevert: Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 3, 403-16(2006) (Pubitemid 43811782)
140. M. J. Sanders, Z. S. Ali, B. D. Hegarty, R. Heath, M. A. Snowden and D. Carling: Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J Biol Chem, in press (2007)
141. O. Goransson, A. McBride, S. A. Hawley, F. A. Ross, N. Shpiro, M. Foretz, B. Viollet, D. G. Hardie and K. Sakamoto: Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem, in press (2007)
142. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki and K. Tobe: Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116, 1784-92(2006) (Pubitemid 44033298)
143. N. Kubota, Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, K. Eto, T. Yamashita, J. Kamon, H. Satoh, W. Yano, P. Froguel, R. Nagai, S. Kimura, T. Kadowaki and T. Noda: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277, 25863-6(2002) (Pubitemid 34967064)
144. K. Ma, A. Cabrero, P. K. Saha, H. Kojima, L. Li, B. H. Chang, A. Paul and L. Chan: Increased beta - oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 277, 34658-61(2002)
145. N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, R. Komuro, N. Ouchi, S. Kihara, Y. Tochino, K. Okutomi, M. Horie, S. Takeda, T. Aoyama, T. Funahashi and Y. Matsuzawa: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8, 731-7(2002) (Pubitemid 34778727)
146. M. Bjursell, A. Ahnmark, Y. M. Bohlooly, L. William-Olsson, M. Rhedin, X. R. Peng, K. Ploj, A. K. Gerdin, G. Arnerup, A. Elmgren, A. L. Berg, J. Oscarsson and D. Linden: Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56, 583-93(2007) (Pubitemid 46348449)
147. T. Yamauchi, Y. Nio, T. Maki, M. Kobayashi, T. Takazawa, M. Iwabu, M. Okada-Iwabu, S. Kawamoto, N. Kubota, T. Kubota, Y. Ito, J. Kamon, A. Tsuchida, K. Kumagai, H. Kozono, Y. Hada, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, M. Awazawa, I. Takamoto, P. Froguel, K. Hara, K. Tobe, R. Nagai, K. Ueki and T. Kadowaki: Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13, 332-9(2007) (Pubitemid 46376688)
148. R. Shibata, N. Ouchi, M. Ito, S. Kihara, I. Shiojima, D. R. Pimentel, M. Kumada, K. Sato, S. Schiekofer, K. Ohashi, T. Funahashi, W. S. Colucci and K. Walsh: Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10, 1384-9(2004) (Pubitemid 40022722)
149. P. E. Durante, K. J. Mustard, S. H. Park, W. W. Winder and D. G. Hardie: Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. Am J Physiol Endocrinol Metab 283, E178-86 (2002) (Pubitemid 34686684)
150. C. Frosig, S. B. Jorgensen, D. G. Hardie, E. A. Richter and J. F. Wojtaszewski: 5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. Am J Physiol Endocrinol Metab 286, E411-7 (2004) (Pubitemid 38292691)
151. C. Roepstorff, M. Thiele, T. Hillig, H. Pilegaard, E. A. Richter, J. F. Wojtaszewski and B. Kiens: Higher skeletal muscle alpha2AMPK activation and lower energy charge and fat oxidation in men than in women during submaximal exercise. J Physiol 574, 125-38(2006) (Pubitemid 43905802)
152. H. J. Koh, D. E. Arnolds, N. Fujii, T. T. Tran, M. J. Rogers, N. Jessen, Y. Li, C. W. Liew, R. C. Ho, M. F. Hirshman, R. N. Kulkarni, C. R. Kahn and L. J. Goodyear: Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 26, 8217-27(2006) (Pubitemid 44748559)
153. D. Klein, H. Pilegaard, J. T. Treebak, T. E. Jensen, B. Viollet, P. Schjerling and J. F. Wojtaszewski: Lack of {alpha}2 5'AMP Activated Protein Kinase enhances Pyruvate Dehydrogenase activity during exercise. Am J Physiol Endocrinol Metab, in press (2007)
154. M. Foretz, N. Taleux, B. Guigas, S. Horman, C. Beauloye, F. Andreelli, L. Bertrand, B. Viollet: Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases. Med Sci 22(4):381-8(2006)